Getty Images
July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a strategic agreement with Windsong Radiology Group, one of US Radiology Specialists, Inc.’s national network of premier providers of diagnostic imaging services located in Western New York. This relationship aims to implement iCAD’s ProFound AI Breast Health at Windsong Radiology center locations.
The ProFound AI Breast Health Suite utilizes artificial intelligence to improve the accuracy and efficiency of mammography readings, thereby reducing false positives and unnecessary biopsies. This technology helps to augment radiologists by providing a concurrent read of screening and diagnostic mammograms, often enhancing early detection of breast cancer.
“We are thrilled to collaborate with US Radiology to bring our advanced AI-powered mammography solutions to a broader patient base,” said Dana Brown, CEO of iCAD, Inc. “This agreement aligns with our mission to create a world where cancer can’t hide and ensure that all patients have access to AI’s capabilities to detect cancer earlier.”
As a leader in women's imaging, Windsong Radiology is setting the standard by adopting the latest advancements in imaging technology. “Our practice is dedicated to clinical excellence for our patients. We are committed to bringing in new innovations that continue to further enhance our radiology expertise and offerings’” said Dr. Raja Cheruvu, President at Windsong Radiology. “We are excited to offer iCAD’s breast AI solutions to our community, a technology to remain at the forefront of breast cancer detection and treatment.”
US Radiology shares this commitment to leveraging cutting-edge technology to provide world-class radiology services across its more than 175 outpatient imaging centers that span 13 states. “Integrating iCAD’s ProFound AI Breast Health Suite into our screening services represents a significant step forward in our ongoing efforts to offer the highest quality imaging services,” said Gerry Lewis, Chief Information Officer of US Radiology Specialists. “This collaboration with iCAD underscores our dedication to utilizing next-generation technology to enhance patient centered outcomes.”
This strategic commercial agreement represents an advancement in breast cancer detection and patient care to advance the standard of care for women.
For more information: www.icadmed.com
September 30, 2026 
